Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.54 |
---|---|
High | 2.54 |
Low | 2.50 |
Bid | -- |
Offer | -- |
Previous close | 2.52 |
Average volume | 0.00 |
---|---|
Shares outstanding | 6.99m |
Free float | 5.44m |
P/E (TTM) | -- |
Market cap | 19.93m USD |
EPS (TTM) | -4.44 USD |
Data delayed at least 15 minutes, as of Sep 19 2024 18:32 BST.
More ▼
Announcements
- Minerva Neurosciences Reports Second Quarter 2024 Financial Results and Business Updates
- Minerva Neurosciences Reports First Quarter 2024 Financial Results and Business Updates
- Minerva Neurosciences Receives Complete Response Letter from FDA for New Drug Application for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia
- Minerva Neurosciences Reports Fourth Quarter and Fiscal Year 2023 Financial Results and Business Updates
- Minerva Neurosciences Reports 2023 Third Quarter Financial Results and Business Updates
More ▼